Wattal Chand, Javeri Yash, Goel Neeraj, Dhar Debashish, Saxena Sonal, Singh Sarman, Oberoi Jaswinder Kaur, Rao B K, Mathur Purva, Manchanda Vikas, Nangia Vivek, Kapil Arti, Rattan Ashok, Ghosh Supradip, Singh Omender, Singh Vinod, Kaur Iqbal, Datta Sanghamitra, Gupta Sharmila Sen
Indian Association of Medical Microbiologists - Delhi Chapter, New Delhi, India.
Indian Society of Critical Care Medicine, New Delhi, India.
Indian J Crit Care Med. 2017 Mar;21(3):154-159. doi: 10.4103/ijccm.IJCCM_365_16.
There is emergence of resistance to the last-line antibiotics such as carbapenems in Intensive Care Units (ICUs), leaving little effective therapeutic options. Since there are no more newer antibiotics in the armamentarium in the near future, it has become imperative that we harness the interdisciplinary knowledge for the best clinical outcome of the patient.
The aim of the conference was to utilize the synergies between the clinical microbiologists and critical care specialists for better patient care and clinical outcome.
A combined continuing medical education program (CME) under the aegis of the Indian Association of Medical Microbiologists - Delhi Chapter and the Indian Society of Critical Care Medicine, Delhi and national capital region was organized to share their expertise on the various topics covering epidemiology, diagnosis, management, and prevention of hospital-acquired infections in ICUs.
It was agreed that synergy between the clinical microbiologists and critical care medicine is required in understanding the scope of laboratory tests, investigative pathway testing, hospital epidemiology, and optimum use of antibiotics. A consensus on the use of rapid diagnostics such as point-of-care tests, matrix-assisted laser desorption ionization-time of flight mass spectrometry, and molecular tests for the early diagnosis of infectious disease was made. It was agreed that stewardship activities along with hospital infection control practices should be further strengthened for better utilization of the antibiotics. Through this CME, we identified the barriers and actionables for appropriate antimicrobial usage in Indian ICUs.
A close coordination between clinical microbiology and critical care medicine opens up avenues to improve antimicrobial prescription practices.
重症监护病房（ICU）中出现了对碳青霉烯类等最后一线抗生素的耐药性，使得有效的治疗选择所剩无几。由于在不久的将来药库中不会有更新的抗生素，因此利用跨学科知识以实现患者最佳临床结局变得势在必行。
本次会议的目的是利用临床微生物学家和重症监护专家之间的协同作用，以提供更好的患者护理并改善临床结局。
在印度医学微生物学家协会德里分会以及德里和国家首都地区的印度重症监护医学学会的支持下，组织了一个联合继续医学教育项目（CME），以分享他们在涵盖ICU医院获得性感染的流行病学、诊断、管理和预防等各个主题方面的专业知识。
与会者一致认为，临床微生物学家和重症监护医学之间需要协同合作，以了解实验室检测的范围、调查途径检测、医院流行病学以及抗生素的最佳使用。就使用即时检验、基质辅助激光解吸电离飞行时间质谱等快速诊断方法以及用于传染病早期诊断的分子检测达成了共识。与会者一致认为，应进一步加强管理活动以及医院感染控制措施，以更好地利用抗生素。通过这次CME，我们确定了印度ICU中合理使用抗菌药物的障碍和可行措施。
临床微生物学和重症监护医学之间的密切协调为改善抗菌药物处方实践开辟了道路。
